Practical Guidelines for Assessing the Clinical Significance of Health-Related Quality of Life Changes within Clinical Trials

Therapeutic Innovation & Regulatory Science

Volumn 37, Issue 1, 2003, Pages 23-31

  Sloan, Jeff ^a   Symonds, Tara ^b   Vargas Chanes, Delfino ^a   Fridley, Brooke ^c  

^a MAYO CLINIC   (United States)

^b PFIZER INC   (United States)

^c E005A Lagomarcino Hall   (United States)

Author keywords

Clinical significance; Effect size; HRQOL; Minimal clinically important difference; Psychometrics

Indexed keywords

EID: 84996253416     PISSN: 21684790     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286150303700105     Document Type: Article

References (26)

1. Wilke RJ, Glick HA, McCarron TJ, et al Quality of life effects of alprostadil therapy for erectile dysfunction. J Urol. 1996; 157: 2124–2128.
2. Juniper EF, Guyatt GH, Willam A, Griffith LE Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol. 1994; 47: 81–87.
3. Juniper EF The value of quality of life in asthma. Eur Respir Rev. 1997; 7: 333–337.
4. Juniper EF Quality of life questionnaires: Does statistically significant = clinically important?. J Allergy Clin Immunol. 1998; 102: 16–17.
5. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Academic Press; 1988.
6. Jaeschke R, Singer J, Guyatt GH Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989; 10: 407–415.
7. Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998; 16: 139–144.
8. Sloan J, Symonds T. Health related quality of life: When does a statistically significant change become clinically significant? Presented at the ISOQOL Educational Workshop, Washington, DC, January, 2001.
9. Guyatt GH, Sullivan MJ, Thompson PJ, et al The 6-minute walk: A new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J. 1985; 132: 919–923.
10. Bittner V, Weiner DH, Yusuf S, et al Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. JAMA. 1993; 270: 1702–1707.
11. Jones PW, Quirk FH, Baveystock CM The St George's Respiratory Questionnaire. Respir Med. 1991; 85 Suppl B: 25–31; Discussion 33–37.
12. Jones PW Quality of life, symptoms and pulmonary function in asthma: Long-term treatment with nedocromil sodium examined in a controlled multicentre trial. Nedocromil Sodium Quality of Life Study Group. Eur Respir J. 1994; 7: 55–62.
13. Jones PW, Bosh TK Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med. 1997; 155: 1283–1289.
14. Pocock SJ Statistical and ethical issues in monitoring clinical trials. Stat Med. 1993; 12(15–16): 1459–1469.
15. Senn SJ, Auclair P. The graphical representation of clinical trials with particular reference to measurements over time. Stat Med. 1990; Nov;9 (11):1287–1302.
16. Sloan JA Asking the obvious questions regarding patient burden. J Clin Oncology. 2002; 20: 4–6.
17. Kazis LE, Anderson JJ, Meenan RF Effect sizes for interpreting changes in health status. Med Care. 1989; 27: S178–189.
18. McCorkle R, Young K. Development of a symptom distress scale. Cancer Nurs. 1978; 1: 373–378.
19. Norman GR, Stratford P, Regehr G. Methodological problems in the retrospective computation of responsiveness to change: The lesson of Cronbach. J Clin Epidemiol. 1997; 50: 869–879.
20. Barber BL, Santanello NC, Epstein RS Impact of the global on patient perceivable change in an asthma specific QOL questionnaire. Qual Life Res. 1996; 5: 117–122.
21. Redelmeier DA, Guyatt GH, Goldstein RS Assessing the minimal important difference in symptoms: A comparison of two techniques. J Clin Epidemiol. 1996; 49: 1215–1219.
22. Cella DF Quality of life outcomes: Measurement and validation. Oncology (Huntingt). 1996; 10: 233–246.
23. Feinstein AR Indexes of contrast and quantitative significance for comparisons of two groups. Stat Med. 1999; 18: 2557–2581.
24. Stucki G, Daltroy L, Katz JN, Johannesson M, Liang MH Interpretation of change scores in ordinal clinical scales and health status measures: The whole may not equal the sum of the parts. J Clin Epidemiol. 1996; 49: 711–717.
25. Bellamy N, Anastassiades TP, Buchanan WW, et al Rheumatoid arthritis antirheumatic drug trials. III. Setting the delta for clinical trials of antirheumatic drugs results of a consensus development (Delphi) exercise. J Rheumatol. 1991; 18: 1908–1915.
26. Bellamy N, Carette S, Ford PM, et al Osteoarthritis antirheumatic drug trials. III. Setting the delta for clinical trials—Results of a consensus development (Delphi) exercise. J Rheumatol. 1992; 19: 451–457.